Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia

New England Journal of Medicine

Volumn 342, Issue 14, 2000, Pages 998-1006

  Aricò, Maurizio ^a   Valsecchi, Maria Grazia ^b   Camitta, Bruce ^c   Schrappe, Martin ^d   Chessells, Judith ^e   Baruchel, André ^f   Gaynon, Paul ^g   Silverman, Lewis ^m   Janka Schaub, Gritta ^h   Kamps, Willem ⁱ   Pui, Ching Hon ^j   Masera, Giuseppe ^k   Conter, V ^m   Riehm, H ^m   Heerema, N ^m   Sallan, S ^m   Auclerc, M F ^m   Pullen, J ^m   Shuster, J ^m   Carroll, A ^m   Raimondi, S ^l   Richards, S ^m   more..

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f SAINT LOUIS HOSPITAL   (France)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h UNIVERSITY OF HAMBURG   (Germany)

ⁱ UNIVERSITY OF GRONINGEN   (Netherlands)

^j UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^k SAN GERARDO HOSPITAL   (Italy)

^l ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^m St Jude Children's Res Hospital ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0034611661     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200004063421402     Document Type: Article

References (42)

1. Pui C-H, Crist WM. Biology and treatment of acute lyraphoblastic leukemia. J Pediatr 1994;124:491-503.
2. Smith M, Bleyer A, Crist W, Murphy S, Sallan SE. Uniform criteria for childhood acute lymphoblastic leukemia risk classification. J Clin Oncol 1996;14:680-1.
3. Riehm H, Reiter A, Schrappe M, et al. Die Corticosteroid-abhängige Dezimierung der Leukämiezellzahl im Blut als Prognosefaktor beider akuten lymphoblastischen Leukämie im Kindesalter (Therapiestudie ALL-BFM 83). Klin Padiatr 1987;199:151-60.
4. Raimondi S. Cytogenetics of acute leukemias. In: Pui C-H, ed. Childhood leukemias. Cambridge, England: Cambridge University Press, 1999:168-96.
5. Schlichen S, Borkhardt A, Reinisch I, et al. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL): a prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM 90 and CoALL-05-92. Leukemia 1996;10:957-63.
6. Suryanarayan K, Hunger SP, Kohler S, et al. Consistent involvement of the bcr gene by 9;22 breakpoints in pediatric acute leukemias. Blood 1991; 77:324-30.
7. Kantarjian HM, Talpaz M, Dhingra K, et al. Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia. Blood 1991;78:2411-8.
8. Maurer J, Janssen JWG, Thiel E, et al. Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet 1991;337:1055-8.
9. Ribeiro RC, Abromowitch M, Raimondi SC, Murphy SB, Behm F, Williams DL. Clinical and biologic hallmarks of the Philadelphia chromosome in childhood acute lymphoblastic leukemia. Blood 1987;70:948-53.
10. Fletcher JA, Lynch EA, Kimball VM, Donnelly M, Tantravahi R, Sallan SE. Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia. Blood 1991; 77:435-9.
11. Pui C-H, Crist WM, Look AT. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 1990;76:1449-63.
12. Crist W, Carroll A, Shuster J, et al. Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome: a Pediatric Oncology Group study. Blood 1990;76:489-94.
13. Uckun FM, Nachman JB, Sather HN, et al. Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: a report from the Children's Cancer Group. Cancer 1998;83:2030-9.
14. Harbott J, Ritterbach J, Ludwig WD, Bartram CR, Reiter A, Lampert F. Clinical significance of cytogenetic studies in childhood acute lymphoblastic leukemia: experience of the BFM trials. Recent Results Cancer Res 1993;131:123-32.
15. Russo C, Carroll A, Kohler S, et al. Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood 1991;77:1050-6.
16. Reiter A, Schrappe M, Ludwig W-D, et al. Chemotherapy in 998 unsclccted childhood acute lymphoblastic leukemia patients: results and conclusions of the multicenter trial ALL-BFM 86. Blood 1994;84:3122-33.
17. Chessells JM, Bailey C, Richards SM. Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Lancet 1995;345:143-8.
18. Roberts WM, Rivera GK, Raimondi SC, et al. Intensive chemotherapy for Philadelphia-chromosome-positive acute lymphoblastic leukaemia. Lancet 1994;343:331-2.
19. Ribeiro RC, Broniscer A, Rivera GK, et al. Philadelphia chromosome-positive acute lymphoblastic leukemia in children: durable responses to chemotherapy associated with low initial white blood cell counts. Leukemia 1997;11:1493-6.
20. Thomas X, Thiebaut A, Olteanu N, et al. Philadelphia chromosome positive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome. Hematol Cell Ther 1998;40:119-28.
21. Bassan R, Rohatiner AZ, Rambaldi A, et al. Clinical sensitivity to anthracyclines in Ph/BCR+ acute lymphoblastic leukemia. Adv Exp Med Biol 1999;457:489-99.
22. Schrappe M, Aricò M, Harbott J, et al. Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome. Blood 1998;92:2730-41.
23. The Cox regression model. In: Marubini E, Valsecchi MG. Analysing survival data from clinical trials and observational studies. Chichester, England: John Wiley, 1995:171-222.
24. Mastrangelo R, Poplack D, Bleyer A, Riccardi R, Sather H, D'Angio G. Report and recommendations of the Rome workshop concerning poor-prognosis acute lymphoblastic leukemia in children: biologic bases for staging, stratification, and treatment. Med Pediatr Oncol 1986;14:191-4.
25. Simon R, Makuch RW. A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non responder bias. Stat Med 1984;3:35-44.
26. Stram DO, Sather H, Wang L. Analysis of time to death after transplantation when transplants are only given to patients in remission. Biometrics 1996;52:1079-86.
27. Conter V, Aricò M, Valsecchi MG, et al. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Haematologica 1998;83:791-9.
28. Schrappe M, Reiter A, Sauter S, et al. Konzeption und Zwischenergebnis der Therapiestudie ALL-BFM 90 zur Behandlung der akuten lymphoblastischen Leukämie bei Kindern und Jugendlichen: Die Bedeutung des initialen Therapieansprechens in Blut und Knochenmark. Klin Padiatr 1994;206:208-21.
29. Gajjar A, Ribeiro R, Hancock ML, et al. Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia. Blood 1995;86:1292-5.
30. Gaynon PS, Bleyer WA, Steinherz PG, et al. Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features. Med Pediatr Oncol 1990;18:273-9.
31. Steinherz PG, Gaynon PS, Breneman IC, et al. Cytoreduction and prognosis in acute lymphoblastic leukemia - the importance of early marrow response: report from the Children's Cancer Group. J Clin Oncol 1996;14:389-98.
32. Pui C-H, Evans WE. Acute lymphoblastic leukemia. N Engl J Med 1998;339:605-15.
33. Conter V, Aricò M, Valsecchi MG, et al. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Munster-based intensive chemotherapy. J Clin Oncol 1995;13: 2497-502.
34. Janka-Schaub GE, Harms D, Goebel U, et al. Randomized comparison of rotational chemotherapy in high-risk acute lymphoblastic leukaemia of childhood - follow up after 9 years. Eur J Pediatr 1996;155: 640-8.
35. Silverman LB, Gelber RD, Young ML, Dalton VK, Barr RD, Sallan SE. Induction failure in acute lymphoblastic leukemia of childhood. Cancer 1999;85:1395-404.
36. Uderzo C, Valsecchi MG, Balduzzi A, et al. Allogeneic bone marrow transplantation versus chemotherapy in high risk childhood acute lymphoblastic leukaemia in first remission. Br J Haematol 1997;96:387-94.
37. Barrett AJ, Horowitz MM, Ash RC, et al. Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1992;79:3067-70.
38. Casper J, Camitta B, Ash R, et al. Bone marrow transplantation for Philadelphia chromosome positive (Ph+) acute lymphocytic leukemia (ALL) using alternative donors. Blood 1992;80:Suppl 1:65a. abstract.
39. Marks DI, Bird JM, Cornish JM, et al. Unrelated donor bone marrow transplantation for children and adolescents with Philadelphia-positive acute lymphoblastic leukemia J Clin Oncol 1998;16:931-6.
40. Nachman JB, Sather NH, Sensel MG, et al. Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy. N Engl J Med 1998;338:1663-71.
41. Valsecchi MG, Masera G. A new challenge in clinical research in childhood ALL: the prospective meta-analysis strategy for intergroup collaboration. Ann Oncol 1996;7:1005-8.
42. Shuster JJ, Gieser PW. Meta-analysis and prospective meta-analysis in childhood leukemia clinical research. Ann Oncol 1996;7:1009-14.